These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21453465)

  • 21. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic response of Plasmodium vivax to chloroquine in Bolivia].
    Añez A; Navarro-Costa D; Yucra O; Garnica C; Melgar V; Moscoso M; Arteaga R; Nakao G
    Biomedica; 2012; 32(4):527-35. PubMed ID: 23715228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring Plasmodium vivax chloroquine sensitivity along China-Myanmar border of Yunnan Province, China during 2008-2013.
    Liu H; Yang HL; Tang LH; Li XL; Huang F; Wang JZ; Li CF; Wang HY; Nie RH; Guo XR; Lin YX; Li M; Xu JW
    Malar J; 2014 Sep; 13():364. PubMed ID: 25224069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
    Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.
    Mekonnen SK; Aseffa A; Berhe N; Teklehaymanot T; Clouse RM; Gebru T; Medhin G; Velavan TP
    Malar J; 2014 Jun; 13():244. PubMed ID: 24964730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of chloroquine for the treatment of Plasmodium vivax in the Saharan zone in Mauritania.
    Ould Ahmedou Salem MS; Mohamed Lemine YO; Deida JM; Lemrabott MA; Ouldabdallahi M; Ba MD; Boukhary AO; Khairy ML; Abdel Aziz MB; Ringwald P; Basco LK; Niang SD; Lebatt SM
    Malar J; 2015 Jan; 14():39. PubMed ID: 25626475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria.
    Chu CS; Phyo AP; Lwin KM; Win HH; San T; Aung AA; Raksapraidee R; Carrara VI; Bancone G; Watson J; Moore KA; Wiladphaingern J; Proux S; Sriprawat K; Winterberg M; Cheah PY; Chue AL; Tarning J; Imwong M; Nosten F; White NJ
    Clin Infect Dis; 2018 Oct; 67(10):1543-1549. PubMed ID: 29889239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.
    Gonzalez-Ceron L; Rodriguez MH; Sandoval MA; Santillan F; Galindo-Virgen S; Betanzos AF; Rosales AF; Palomeque OL
    Malar J; 2015 Oct; 14():426. PubMed ID: 26518132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survey of in vivo sensitivity to chloroquine by Plasmodium falciparum and P. vivax in Lombok, Indonesia.
    Fryauff DJ; Baird JK; Candradikusuma D; Masbar S; Sutamihardja MA; Leksana B; Tuti S; Marwoto H; Richie T; Romzan A
    Am J Trop Med Hyg; 1997 Feb; 56(2):241-4. PubMed ID: 9080887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar.
    Guthmann JP; Pittet A; Lesage A; Imwong M; Lindegardh N; Min Lwin M; Zaw T; Annerberg A; de Radiguès X; Nosten F
    Trop Med Int Health; 2008 Jan; 13(1):91-8. PubMed ID: 18291007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imported chloroquine-resistant Plasmodium vivax in Singapore: case report and literature review.
    Lim PL; Mok YJ; Lye DC; Leo YS
    J Travel Med; 2010; 17(1):69-71. PubMed ID: 20074103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmodium vivax associated severe malaria complications among children in some malaria endemic areas of Ethiopia.
    Ketema T; Bacha K
    BMC Public Health; 2013 Jul; 13():637. PubMed ID: 23834734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.
    Saravu K; Kumar R; Ashok H; Kundapura P; Kamath V; Kamath A; Mukhopadhyay C
    PLoS One; 2016; 11(6):e0157666. PubMed ID: 27315280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia.
    Assefa A; Mohammed H; Anand A; Abera A; Sime H; Minta AA; Tadesse M; Tadesse Y; Girma S; Bekele W; Etana K; Alemayehu BH; Teka H; Dilu D; Haile M; Solomon H; Moriarty LF; Zhou Z; Svigel SS; Ezema B; Tasew G; Woyessa A; Hwang J; Murphy M
    Malar J; 2022 Dec; 21(1):359. PubMed ID: 36451216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of Plasmodium vivax Resistance to Chloroquine in French Guiana.
    Musset L; Heugas C; Naldjinan R; Blanchet D; Houze P; Abboud P; Volney B; Walter G; Lazrek Y; Epelboin L; Pelleau S; Ringwald P; Legrand E; Demar M; Djossou F
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic efficacy of artesunate in Plasmodium vivax malaria in Thailand.
    Hamedi Y; Safa O; Zare S; Tan-ariya P; Kojima S; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):570-4. PubMed ID: 15689068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis.
    Commons RJ; Simpson JA; Thriemer K; Humphreys GS; Abreha T; Alemu SG; Añez A; Anstey NM; Awab GR; Baird JK; Barber BE; Borghini-Fuhrer I; Chu CS; D'Alessandro U; Dahal P; Daher A; de Vries PJ; Erhart A; Gomes MSM; Gonzalez-Ceron L; Grigg MJ; Heidari A; Hwang J; Kager PA; Ketema T; Khan WA; Lacerda MVG; Leslie T; Ley B; Lidia K; Monteiro WM; Nosten F; Pereira DB; Phan GT; Phyo AP; Rowland M; Saravu K; Sibley CH; Siqueira AM; Stepniewska K; Sutanto I; Taylor WRJ; Thwaites G; Tran BQ; Tran HT; Valecha N; Vieira JLF; Wangchuk S; William T; Woodrow CJ; Zuluaga-Idarraga L; Guerin PJ; White NJ; Price RN
    Lancet Infect Dis; 2018 Sep; 18(9):1025-1034. PubMed ID: 30033231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.
    Lo E; Hemming-Schroeder E; Yewhalaw D; Nguyen J; Kebede E; Zemene E; Getachew S; Tushune K; Zhong D; Zhou G; Petros B; Yan G
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005806. PubMed ID: 28746333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmodium vivax morbidity after radical cure: A cohort study in Central Vietnam.
    Pham TV; Nguyen HV; Aguirre AR; Nguyen VV; A Cleves M; Nguyen XX; Nguyen TT; Tran DT; Le HX; Hens N; Rosanas-Urgell A; D'Alessandro U; Speybroeck N; Erhart A
    PLoS Med; 2019 May; 16(5):e1002784. PubMed ID: 31100064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.